Skip to content
YCW26ยท AI

Ditto Biosciences

Evolutionary intelligence for autoimmune disease

ActiveChecked 18h ago
Batch
W26
Status, per YC
Active
Team size
3
HQ
San Francisco, CA
In W26199 companies, 80% AI

Founders

  • Dennis SunFounder/CEO
  • Adair BorgesFounder
  • Emily WeissFounder

Same space

About Ditto Biosciences

Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction

San Francisco, CA, USA

Ditto Biosciences: questions

Which YC batch was Ditto Biosciences in?

Ditto Biosciences was in Y Combinator's Winter 2026 batch (W26).

Is Ditto Biosciences still active?

Y Combinator lists Ditto Biosciences as active.

Who founded Ditto Biosciences?

Ditto Biosciences's founders, as listed on its YC page: Dennis Sun (Founder/CEO), Adair Borges (Founder), Emily Weiss (Founder).

Where is Ditto Biosciences based?

Ditto Biosciences lists San Francisco, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.